DRUGS AFFECTING LIPID METABOLISMMEINERTZ H; FAERGEMAN O.1980; SIDE EFF. DRUGS ANN.; NLD; DA. 1980; VOL. 4; PP. 316-321; BIBL. 12 REF.Article

Introduction : Apolipoproteins and guidelines for prevention of cardiovascular disease : Symposium: APOB and APOA-I - New Markers of Cardiovascular RiskFAERGEMAN, O.Journal of internal medicine. 2006, Vol 259, Num 5, pp 434-436, issn 0954-6820, 3 p.Article

Total mortality in cardiovascular risk factor intervention trialsFAERGEMAN, O.Scandinavian journal of clinical & laboratory investigation. Supplement. 1990, Vol 50, pp 7-13, issn 0085-591X, 7 p., Suppl. 199Conference Paper

Action limits in hyperlipidemiaFÆRGEMAN, O.Scandinavian journal of clinical & laboratory investigation. Supplement. 1990, Vol 50, Num 198, pp 82-85, issn 0085-591X, 4 p.Conference Paper

METABOLISM OF CHOLESTERYL ESTERS OF RAT VERY LOW DENSITY LIPOPROTEINS = METABOLISME DES ESTERS DE CHOLESTEROL DES LIPOPROTEINES DE TRES FAIBLE DENSITE CHEZ LE RATFAERGEMAN O; HAVEL RJ.1975; J. CLIN. INVEST.; U.S.A.; DA. 1975; VOL. 55; NO 6; PP. 1210-1218; BIBL. 43REFArticle

NORMAL ARTERIAL BLOOD GASES DURING EXPERIMENTAL HYPERTRIGLYCERIDEMIA IN THE RAT. = NORMALITE DES GAZ DU SANG ARTERIEL AU COURS DE L'HYPERTRIGLYCERIDEMIE EXPERIMENTALE CHEZ LE RATMJOS OD; FAERGEMAN O.1975; SCAND. J. CLIN. LAB. INVEST.; NORWAY; DA. 1975; VOL. 35; NO 7; PP. 645-648; BIBL. 12 REF.Article

METABOLISM OF CHOLESTERYL ESTERS OF VERY LOW DENSITY LIPOPROTEINS IN THE GUINEA PIG.BARTER P; FAERGEMAN O; HAVEL RJ et al.1977; METABOLISM; U.S.A.; DA. 1977; VOL. 26; NO 6; PP. 615-622; BIBL. 1 P.Article

PLASMA LIPIDS AND LIPOPROTEINS IN LONG-TERM BETA-ADRENERGIC BLOCKADEJURGENSEN HJ; MEINERTZ H; FAERGEMAN O et al.1982; ACTA MED. SCAND.; ISSN 0001-6101; SWE; DA. 1982; VOL. 211; NO 6; PP. 449-452; BIBL. 38 REF.Article

SERUM LIPOPROTEIN AND LYMPHOCYTE LDL RECEPTOR STUDIES IN PARENTS AND CHILDREN WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIAJOHANSEN KB; FAERGEMAN O; ANDERSEN GE et al.1982; SCAND. J. CLIN. LAB. INVEST.; ISSN 0036-5513; NOR; DA. 1982; VOL. 42; NO 2; PP. 113-118; BIBL. 16 REF.Article

Ischaemic left ventricular failure : evidence of sustained benefit after 18 months' treatment with xamoterolVIGHOLT-SOÊRENSEN, E; FAERGEMAN, O.British heart journal. 1990, Vol 64, Num 3, pp 186-189, issn 0007-0769, 4 p.Article

COATED PITS AND PINOCYTOSIS OF CATIONIZED FERRITIN IN HUMAN SKIN FIBROBLASTSVAN DEURS B; NICAUSEN K; FAERGEMAN O et al.1982; EUR. J. CELL BIOL.; ISSN 0171-9335; DEU; DA. 1982; VOL. 27; NO 2; PP. 270-278; BIBL. 40 REF.Article

EXCESSIVE HYPERTRIGLYCERIDEMIA AND PANCREATITIS IN PREGNANCYLYKKESFELDT G; BOCK JE; PEDERSEN FD et al.1981; ACTA OBSTET. GYNECOL. SCAND.; ISSN 0001-6349; SWE; DA. 1981; VOL. 60; NO 1; PP. 79-82; BIBL. 16 REF.Article

THE MAGNITUDE OF METABOLICALLY INDUCED CHANGES IN THE DENSITY OF HUMAN LOW-DENSITY LIPOPROTEINSWEECH P; MILLS G; MEINERTZ H et al.1981; SCAND. J. CLIN. LAB. INVEST.; ISSN 0036-5513; NOR; DA. 1981; VOL. 41; NO 3; PP. 253-261; BIBL. 28 REF.Article

EFFECTS AND SIDE-EFFECTS OF PARTIAL ILEAL BY-PASS SURGERY FOR FAMILIAL HYPERCHOLESTEROLAEMIAFAERGEMAN O; MEINERTZ H; HYLANDER E et al.1982; ; GUT; ISSN 0017-5749; GBR; DA. 1982; VOL. 23; NO 7; PP. 558-563; BIBL. 22 REF.Article

Soy protein and casein in cholesterol-enriched diets: effects on plasma lipoproteins in normolipidemic subjectsMEINERTZ, H; NILAUSEN, K; FAERGEMAN, O et al.The American journal of clinical nutrition. 1989, Vol 50, Num 4, pp 786-793, issn 0002-9165Article

Evolution of statin therapy: an ongoing storyFAERGEMAN, O.European heart journal supplements. 2004, Vol 6, Num A, pp A3-A7, issn 1520-765XConference Paper

Methods for detecting coronary disease: epidemiology and clinical managementFAERGEMAN, O.Acta physiologica scandinavica. 2002, Vol 176, Num 2, pp 161-165, issn 0001-6772Conference Paper

Challenges to best practice : why are guidelines not implemented?FAERGEMAN, O.European heart journal supplements. 1999, Vol 1, Num J, pp J12-J17, issn 1520-765XConference Paper

Effects of xamoterol, a β₁ adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricleVIGHOLT-SØRENSEN, E; FAERGEMAN, O; SNOW, H. M et al.British heart journal. 1989, Vol 62, Num 5, pp 335-341, issn 0007-0769Article

Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the worldGERDES, L. U; KLAUSEN, I. C; SIHM, I et al.Genetic epidemiology. 1992, Vol 9, Num 3, pp 155-167, issn 0741-0395Article

Patients' attitudes toward detection of heterozygous familial hypercholesterolemiaANDERSEN, L. K; JENSEN, H. K; JUUL, S et al.Archives of internal medicine (1960). 1997, Vol 157, Num 5, pp 553-560, issn 0003-9926Article

Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled studyVIGHOLT SORENSEN, E; STERNDORFF, B; ANDERSEN, M. F et al.Cardiovascular drugs and therapy. 1989, Vol 3, Num 2, pp 203-209Article

Pharmacokinetics of xamoterol after intravenous and oral administration to patients with chronic heart failureVIGHOLT SORENSEN, E; FAERGEMAN, O; DAY, M et al.European journal of clinical pharmacology. 1988, Vol 35, Num 2, pp 183-185, issn 0031-6970Article

Danish singles have a twofold risk of acute coronary syndrome : data from a cohort of 138 290 personsNIELSEN, K. M; FAERGEMAN, O; LARSEN, M. L et al.Journal of epidemiology and community health (1979). 2006, Vol 60, Num 8, pp 721-728, issn 0143-005X, 8 p.Article

Generation of analytic plasma lipoprotein profiles using two prepacked superose 6B columnsULRIK GERDES, L; GERDES, C; KLAUSEN, I. B et al.Clinica chimica acta. 1992, Vol 205, Num 1-2, pp 1-9, issn 0009-8981Article